Sign inGet started

SGMT

Sagimet Biosciences Inc.CIK 1400118 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$7.58M
4 trades · 1 insiders
Net · 90d
$-7.58M
Insiders on file
23

AI insights for SGMT PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for SGMT
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$7.18M2026-08-11 buys — 2026-08-11 sales $402.2K08-112026-08-14 buys — 2026-08-14 sales $7.18M08-14
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
Kemble GeorgeExecutive Chairman45$0$8.13M2026-08-14
Rozek ElizabethGeneral Counsel and CCO14$0$228.1K2026-07-20
Happel DavidPresident & CEO14$71.7K$1.16M2026-07-20
Jarrett JenniferDirector3$0$02026-06-12
Phillips Anne M.Director3$0$02026-06-12
Hoelscher Paul W.Director4$0$02026-06-12
GRAMMER ELIZABETH ADirector5$0$02026-06-12
SEIDENBERG BETH CDirector19$750.0K$02026-06-12
Chauche ThierryChief Financial Officer7$0$7.0K2026-05-28
Grauer AndreasChief Medical Officer2$0$02026-05-28
Martins Eduardo BrunoChief Medical Officer12$0$121.0K2026-02-19
Walbert Timothy PDirector3$0$02025-06-09
Parsey MerdadDirector15$0$02024-06-05
NEA 13 GP, Ltd10% Owner3$0$02024-01-29
NEW ENTERPRISE ASSOCIATES 13 LP10% Owner1$0$02024-01-29
BASKETT FOREST10% Owner4$0$02024-01-29
SANDELL SCOTT D10% Owner4$0$02024-01-29
KERINS PATRICK J10% Owner17$480.0K$10.6K2024-01-29
Wu Jinzi JasonDirector5$0$02023-07-18
Rimac Anthony MChief Operating Officer2$0$02023-07-18
Hom DennisChief Financial Officer6$0$02023-07-18
KPCB PANDEMIC & BIO DEFENSE FUND LLC10% Owner10$0$02023-07-18
Rodgers Richard JDirector6$0$02023-07-18

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Kemble GeorgeDirector M Exercise deriv2026-08-142026-08-17326,618— $031,455SEC↗
Kemble GeorgeDirector M Exercise deriv2026-08-142026-08-1724,369— $011,608SEC↗
Kemble GeorgeDirector S Sale2026-08-142026-08-17350,987$10.23 $3.59M62,161SEC↗
Kemble GeorgeDirector M Exercise2026-08-142026-08-1724,369$6.36 $155.0K413,148SEC↗
Kemble GeorgeDirector M Exercise2026-08-142026-08-17326,618$6.36 $2.08M388,779SEC↗
Kemble GeorgeDirector M Exercise deriv2026-08-142026-08-1724,369— $011,608SEC↗
Kemble GeorgeDirector M Exercise deriv2026-08-142026-08-17326,618— $031,455SEC↗
Kemble GeorgeDirector S Sale2026-08-142026-08-17350,987$10.23 $3.59M62,161SEC↗
Kemble GeorgeDirector M Exercise2026-08-142026-08-1724,369$6.36 $155.0K413,148SEC↗
Kemble GeorgeDirector M Exercise2026-08-142026-08-17326,618$6.36 $2.08M388,779SEC↗
Kemble GeorgeDirector M Exercise deriv2026-08-112026-08-1210,455— $035,977SEC↗
Kemble GeorgeDirector M Exercise deriv2026-08-112026-08-129,751— $0358,073SEC↗
Kemble GeorgeDirector M Exercise2026-08-112026-08-1210,455$6.36 $66.5K82,367SEC↗
Kemble GeorgeDirector S Sale2026-08-112026-08-1220,206$9.95 $201.0K62,161SEC↗
Kemble GeorgeDirector M Exercise2026-08-112026-08-129,751$6.36 $62.0K71,912SEC↗
Kemble GeorgeDirector M Exercise deriv2026-08-112026-08-1210,455— $035,977SEC↗
Kemble GeorgeDirector M Exercise deriv2026-08-112026-08-129,751— $0358,073SEC↗
Kemble GeorgeDirector S Sale2026-08-112026-08-1220,206$9.95 $201.1K62,161SEC↗
Kemble GeorgeDirector M Exercise2026-08-112026-08-1210,455$6.36 $66.5K82,367SEC↗
Kemble GeorgeDirector M Exercise2026-08-112026-08-129,751$6.36 $62.0K71,912SEC↗
Kemble GeorgeDirector S Sale2026-07-202026-07-2218,844$7.46 $140.6K62,161SEC↗
Rozek ElizabethChief Legal & Admin. Officer S Sale2026-07-202026-07-2210,545$7.76 $81.8K224,414SEC↗
Happel DavidPresident & CEO S Sale2026-07-202026-07-2264,051$7.76 $497.0K741,570SEC↗
Phillips Anne M.Director A Award deriv2026-06-122026-06-1539,567— $039,567SEC↗
Kemble GeorgeDirector A Award deriv2026-06-122026-06-1539,567— $039,567SEC↗
GRAMMER ELIZABETH ADirector A Award deriv2026-06-122026-06-1539,567— $039,567SEC↗
Jarrett JenniferDirector A Award deriv2026-06-122026-06-1539,567— $039,567SEC↗
Hoelscher Paul W.Director A Award deriv2026-06-122026-06-1539,567— $039,567SEC↗
SEIDENBERG BETH CDirector A Award deriv2026-06-122026-06-1539,567— $039,567SEC↗
Happel DavidPresident & CEO A Award deriv2026-05-282026-06-01300,000— $0300,000SEC↗
Rozek ElizabethChief Legal & Admin. Officer A Award deriv2026-05-282026-06-01100,000— $0100,000SEC↗
Grauer AndreasChief Medical Officer A Award deriv2026-05-282026-06-0135,000— $035,000SEC↗
Chauche ThierryChief Financial Officer A Award deriv2026-05-282026-06-0150,000— $050,000SEC↗
Grauer AndreasChief Medical Officer A Award deriv2026-04-202026-05-14264,759— $0264,759SEC↗
Chauche ThierryChief Financial Officer A Award deriv2026-02-192026-02-2088,000— $088,000SEC↗
Happel DavidPresident & CEO A Award deriv2026-02-192026-02-20256,000— $0256,000SEC↗
Martins Eduardo BrunoChief Medical Officer A Award deriv2026-02-192026-02-2088,000— $088,000SEC↗
Rozek ElizabethChief Legal & Admin. Officer A Award deriv2026-02-192026-02-2088,000— $088,000SEC↗
Chauche ThierryChief Financial Officer A Award2026-02-192026-02-2044,000— $059,688SEC↗
Happel DavidPresident & CEO A Award2026-02-192026-02-20128,000— $0805,621SEC↗
Martins Eduardo BrunoChief Medical Officer A Award2026-02-192026-02-2044,000— $0147,296SEC↗
Rozek ElizabethChief Legal & Admin. Officer A Award2026-02-192026-02-2044,000— $0234,959SEC↗
Rozek ElizabethChief Legal & Admin. Officer S Sale2026-02-102026-02-122,622$5.36 $14.1K190,959SEC↗
Martins Eduardo BrunoChief Medical Officer S Sale2026-02-102026-02-123,640$5.36 $19.5K103,296SEC↗
Chauche ThierryChief Financial Officer S Sale2026-02-102026-02-121,312$5.36 $7.0K15,688SEC↗
Happel DavidPresident & CEO S Sale2026-02-102026-02-1212,101$5.36 $64.9K677,621SEC↗
Kemble GeorgeExecutive Chairman S Sale2025-11-202025-11-2137,688$7.69 $289.8K81,005SEC↗
Rozek ElizabethChief Legal & Admin. Officer A Award deriv2025-11-042025-11-0613,367— $013,367SEC↗
Rozek ElizabethChief Legal & Admin. Officer A Award2025-11-042025-11-069,855— $0193,581SEC↗
Rozek ElizabethGeneral Counsel and CCO S Sale2025-07-212025-07-2310,780$9.13 $98.4K183,726SEC↗
Martins Eduardo BrunoChief Medical Officer S Sale2025-07-212025-07-238,277$9.13 $75.6K106,936SEC↗
Happel DavidPresident & CEO S Sale2025-07-212025-07-2365,478$9.13 $597.8K689,722SEC↗
GRAMMER ELIZABETH ADirector A Award deriv2025-06-092025-06-1032,250— $032,250SEC↗
Hoelscher Paul W.Director A Award deriv2025-06-092025-06-1032,250— $032,250SEC↗
Jarrett JenniferDirector A Award deriv2025-06-092025-06-1027,268— $027,268SEC↗
Kemble GeorgeDirector A Award deriv2025-06-092025-06-1032,250— $032,250SEC↗
Phillips Anne M.Director A Award deriv2025-06-092025-06-1027,268— $027,268SEC↗
SEIDENBERG BETH CDirector A Award deriv2025-06-092025-06-1032,250— $032,250SEC↗
Walbert Timothy PDirector A Award deriv2025-06-092025-06-1032,250— $032,250SEC↗
SEIDENBERG BETH CDirector A Award deriv2025-06-062025-06-1028,522— $028,522SEC↗
Chauche ThierryChief Financial Officer A Award deriv2025-02-062025-02-0769,000— $069,000SEC↗
Rozek ElizabethGeneral Counsel and CCO A Award deriv2025-02-062025-02-07138,000— $0138,000SEC↗
Happel DavidPresident & CEO A Award deriv2025-02-062025-02-07472,000— $0472,000SEC↗
Martins Eduardo BrunoChief Medical Officer A Award deriv2025-02-062025-02-07138,000— $0138,000SEC↗
Chauche ThierryChief Financial Officer A Award2025-02-062025-02-0717,000— $017,000SEC↗
Rozek ElizabethGeneral Counsel and CCO A Award2025-02-062025-02-0734,000— $0194,506SEC↗
Happel DavidPresident & CEO A Award2025-02-062025-02-07116,000— $0755,200SEC↗
Martins Eduardo BrunoChief Medical Officer A Award2025-02-062025-02-0734,000— $0115,213SEC↗
Phillips Anne M.Director A Award deriv2024-08-012024-08-05113,895— $0113,895SEC↗
Jarrett JenniferDirector A Award deriv2024-08-012024-08-05113,895— $0113,895SEC↗
Kemble GeorgeExecutive Chairman S Sale2024-07-232024-07-2523,625$3.17 $74.9K118,693SEC↗
Kemble GeorgeExecutive Chairman S Sale2024-07-192024-07-2314,062$3.10 $43.6K142,318SEC↗
Rozek ElizabethGeneral Counsel and CCO S Sale2024-07-192024-07-2310,914$3.10 $33.8K160,506SEC↗
Martins Eduardo BrunoChief Medical Officer S Sale2024-07-192024-07-238,357$3.10 $25.9K81,213SEC↗
GRAMMER ELIZABETH ADirector A Award deriv2024-06-052024-06-0751,459— $051,459SEC↗
Hoelscher Paul W.Director A Award deriv2024-06-052024-06-079,279— $09,279SEC↗
Parsey MerdadDirector A Award deriv2024-06-052024-06-0751,459— $051,459SEC↗
SEIDENBERG BETH CDirector A Award deriv2024-06-052024-06-0751,459— $051,459SEC↗
Walbert Timothy PDirector A Award deriv2024-06-052024-06-079,279— $09,279SEC↗
Chauche ThierryChief Financial Officer A Award deriv2024-05-062024-05-08587,181— $0587,181SEC↗
Hoelscher Paul W.Director A Award deriv2024-04-012024-04-0373,014— $073,014SEC↗
Walbert Timothy PDirector A Award deriv2024-04-012024-04-0373,014— $073,014SEC↗
Happel DavidPresident & CEO P Buy2024-03-262024-03-2812,100$5.27 $63.8K639,200SEC↗
NEW ENTERPRISE ASSOCIATES 13 L10% Owner J Other2024-01-292024-01-31850,000— $03,000,275SEC↗
NEA 13 GP, Ltd10% Owner J Other2024-01-292024-01-31260,950— $00SEC↗
NEA 13 GP, Ltd10% Owner J Other2024-01-292024-01-31260,950— $0260,950SEC↗
NEA 13 GP, Ltd10% Owner J Other2024-01-292024-01-31850,000— $03,000,275SEC↗
BASKETT FOREST10% Owner J Other2024-01-292024-01-31850,000— $03,000,275SEC↗
BASKETT FOREST10% Owner J Other2024-01-292024-01-3111,300— $011,300SEC↗
BASKETT FOREST10% Owner J Other2024-01-292024-01-31260,950— $0260,950SEC↗
BASKETT FOREST10% Owner J Other2024-01-292024-01-31260,950— $00SEC↗
KERINS PATRICK J10% Owner J Other2024-01-292024-01-31260,950— $00SEC↗
KERINS PATRICK J10% Owner J Other2024-01-292024-01-31850,000— $03,000,275SEC↗
KERINS PATRICK J10% Owner J Other2024-01-292024-01-31260,950— $0260,950SEC↗
KERINS PATRICK J10% Owner J Other2024-01-292024-01-3113,139— $013,139SEC↗
SANDELL SCOTT D10% Owner J Other2024-01-292024-01-31260,950— $00SEC↗
SANDELL SCOTT D10% Owner J Other2024-01-292024-01-31850,000— $03,000,275SEC↗
SANDELL SCOTT D10% Owner J Other2024-01-292024-01-316,997— $06,997SEC↗
SANDELL SCOTT D10% Owner J Other2024-01-292024-01-31260,950— $0260,950SEC↗
Happel DavidPresident & CEO P Buy2023-12-072023-12-081,600$4.10 $6.6K627,100SEC↗
Happel DavidPresident & CEO A Award2023-11-172023-11-21624,910— $0625,500SEC↗
Kemble GeorgeExecutive Chairman A Award2023-11-172023-11-21150,750— $0156,380SEC↗
Martins Eduardo BrunoChief Medical Officer A Award2023-11-172023-11-2189,570— $089,570SEC↗
Rozek ElizabethGeneral Counsel and CCO A Award2023-11-172023-11-21171,420— $0171,420SEC↗
Happel DavidPresident & CEO P Buy2023-11-162023-11-20590$2.35 $1.4K590SEC↗
Kemble GeorgeExecutive Chairman M Exercise deriv2023-09-072023-09-085,630— $00SEC↗
Kemble GeorgeExecutive Chairman M Exercise2023-09-072023-09-085,630$0.79 $4.4K5,630SEC↗
GRAMMER ELIZABETH ADirector A Award deriv2023-07-182023-07-2049,533— $049,533SEC↗
GRAMMER ELIZABETH ADirector D To issuer deriv2023-07-182023-07-2049,533— $00SEC↗
Happel DavidPresident & CEO A Award deriv2023-07-182023-07-201,011,826— $01,011,826SEC↗
Happel DavidPresident & CEO D To issuer deriv2023-07-182023-07-201,011,826— $00SEC↗
Hom DennisChief Financial Officer D To issuer deriv2023-07-182023-07-20111,438— $00SEC↗
Hom DennisChief Financial Officer A Award deriv2023-07-182023-07-20111,438— $0111,438SEC↗
Hom DennisChief Financial Officer D To issuer deriv2023-07-182023-07-209,286— $00SEC↗
Hom DennisChief Financial Officer A Award deriv2023-07-182023-07-209,286— $09,286SEC↗
Hom DennisChief Financial Officer D To issuer deriv2023-07-182023-07-20136,846— $00SEC↗
Hom DennisChief Financial Officer A Award deriv2023-07-182023-07-20136,846— $0136,846SEC↗
Kemble GeorgeDirector A Award deriv2023-07-182023-07-20367,824— $0367,824SEC↗
Kemble GeorgeDirector D To issuer deriv2023-07-182023-07-20367,824— $00SEC↗
Kemble GeorgeDirector A Award deriv2023-07-182023-07-2026,352— $026,352SEC↗
Kemble GeorgeDirector D To issuer deriv2023-07-182023-07-2026,352— $00SEC↗
Kemble GeorgeDirector D To issuer deriv2023-07-182023-07-207,147— $00SEC↗
Kemble GeorgeDirector A Award deriv2023-07-182023-07-203,179— $03,179SEC↗
Kemble GeorgeDirector D To issuer deriv2023-07-182023-07-203,179— $00SEC↗
Kemble GeorgeDirector A Award deriv2023-07-182023-07-205,630— $05,630SEC↗
Kemble GeorgeDirector D To issuer deriv2023-07-182023-07-205,630— $00SEC↗
Kemble GeorgeDirector D To issuer deriv2023-07-182023-07-2046,432— $00SEC↗
Kemble GeorgeDirector A Award deriv2023-07-182023-07-2046,432— $046,432SEC↗
Kemble GeorgeDirector D To issuer deriv2023-07-182023-07-20526,332— $00SEC↗
Kemble GeorgeDirector A Award deriv2023-07-182023-07-20526,332— $0526,332SEC↗
Kemble GeorgeDirector D To issuer deriv2023-07-182023-07-2021,173— $00SEC↗
Kemble GeorgeDirector A Award deriv2023-07-182023-07-2021,173— $021,173SEC↗
Kemble GeorgeDirector A Award deriv2023-07-182023-07-207,147— $07,147SEC↗
Martins Eduardo BrunoChief Medical Officer A Award deriv2023-07-182023-07-2044,009— $044,009SEC↗
Martins Eduardo BrunoChief Medical Officer D To issuer deriv2023-07-182023-07-20198,132— $00SEC↗
Martins Eduardo BrunoChief Medical Officer A Award deriv2023-07-182023-07-20198,132— $0198,132SEC↗
Martins Eduardo BrunoChief Medical Officer D To issuer deriv2023-07-182023-07-2044,009— $00SEC↗
Parsey MerdadDirector D To issuer deriv2023-07-182023-07-20144— $00SEC↗
Parsey MerdadDirector A Award deriv2023-07-182023-07-203,349— $03,349SEC↗
Parsey MerdadDirector D To issuer deriv2023-07-182023-07-203,349— $00SEC↗
Parsey MerdadDirector A Award deriv2023-07-182023-07-202,086— $02,086SEC↗
Parsey MerdadDirector A Award deriv2023-07-182023-07-20144— $0144SEC↗
Parsey MerdadDirector D To issuer deriv2023-07-182023-07-2023,216— $00SEC↗
Parsey MerdadDirector A Award deriv2023-07-182023-07-2023,216— $023,216SEC↗
Parsey MerdadDirector D To issuer deriv2023-07-182023-07-2023,839— $00SEC↗
Parsey MerdadDirector A Award deriv2023-07-182023-07-2023,839— $023,839SEC↗
Parsey MerdadDirector D To issuer deriv2023-07-182023-07-202,086— $00SEC↗
Parsey MerdadDirector C Conversion deriv2023-07-182023-07-20327,309— $00SEC↗
Rimac Anthony MChief Operating Officer A Award deriv2023-07-182023-07-20242,142— $0242,142SEC↗
Rimac Anthony MChief Operating Officer D To issuer deriv2023-07-182023-07-20242,142— $00SEC↗
Rodgers Richard JDirector D To issuer deriv2023-07-182023-07-201,976— $00SEC↗
Rodgers Richard JDirector A Award deriv2023-07-182023-07-2023,216— $023,216SEC↗
Rodgers Richard JDirector A Award deriv2023-07-182023-07-201,976— $01,976SEC↗
Rodgers Richard JDirector D To issuer deriv2023-07-182023-07-2023,216— $00SEC↗
Rodgers Richard JDirector A Award deriv2023-07-182023-07-2023,839— $023,839SEC↗
Rodgers Richard JDirector D To issuer deriv2023-07-182023-07-2023,839— $00SEC↗
Rozek ElizabethGeneral Counsel and CCO D To issuer deriv2023-07-182023-07-20242,142— $00SEC↗
Rozek ElizabethGeneral Counsel and CCO A Award deriv2023-07-182023-07-20242,142— $0242,142SEC↗
Wu Jinzi JasonDirector C Conversion deriv2023-07-182023-07-20108,471,634— $00SEC↗
Wu Jinzi JasonDirector D To issuer deriv2023-07-182023-07-2023,216— $00SEC↗
Wu Jinzi JasonDirector A Award deriv2023-07-182023-07-2023,216— $023,216SEC↗
Wu Jinzi JasonDirector C Conversion deriv2023-07-182023-07-2023,041,474— $00SEC↗
SEIDENBERG BETH CDirector C Conversion deriv2023-07-182023-07-206,737,254— $00SEC↗
SEIDENBERG BETH CDirector C Conversion deriv2023-07-182023-07-206,103,580— $00SEC↗
SEIDENBERG BETH CDirector C Conversion deriv2023-07-182023-07-208,596,589— $00SEC↗
SEIDENBERG BETH CDirector C Conversion deriv2023-07-182023-07-208,596,590— $00SEC↗
SEIDENBERG BETH CDirector C Conversion deriv2023-07-182023-07-20493,370— $00SEC↗
SEIDENBERG BETH CDirector C Conversion deriv2023-07-182023-07-20539,006— $00SEC↗
SEIDENBERG BETH CDirector A Award deriv2023-07-182023-07-2023,216— $023,216SEC↗
SEIDENBERG BETH CDirector D To issuer deriv2023-07-182023-07-2023,216— $00SEC↗
SEIDENBERG BETH CDirector C Conversion deriv2023-07-182023-07-2020,430,107— $00SEC↗
SEIDENBERG BETH CDirector C Conversion deriv2023-07-182023-07-20103,127,234— $00SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner C Conversion deriv2023-07-182023-07-20539,006— $00SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner C Conversion deriv2023-07-182023-07-206,103,580— $00SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner C Conversion deriv2023-07-182023-07-208,596,589— $00SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner C Conversion deriv2023-07-182023-07-208,596,590— $00SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner C Conversion deriv2023-07-182023-07-20103,127,234— $00SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner C Conversion deriv2023-07-182023-07-2020,430,107— $00SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner C Conversion deriv2023-07-182023-07-20493,370— $00SEC↗
KERINS PATRICK J10% Owner C Conversion deriv2023-07-182023-07-201,301,130— $00SEC↗
KERINS PATRICK J10% Owner X Exercise deriv2023-07-182023-07-2013,404— $00SEC↗
KERINS PATRICK J10% Owner C Conversion deriv2023-07-182023-07-2023,041,474— $00SEC↗
KERINS PATRICK J10% Owner C Conversion deriv2023-07-182023-07-20237,893,958— $00SEC↗
KERINS PATRICK J10% Owner C Conversion deriv2023-07-182023-07-2011,363,635— $00SEC↗
KERINS PATRICK J10% Owner C Conversion deriv2023-07-182023-07-2011,363,634— $00SEC↗
KERINS PATRICK J10% Owner C Conversion deriv2023-07-182023-07-2014,659,091— $00SEC↗
Parsey MerdadDirector D To issuer2023-07-182023-07-208,677— $00SEC↗
Parsey MerdadDirector A Award2023-07-182023-07-208,677— $08,677SEC↗
Parsey MerdadDirector C Conversion2023-07-182023-07-204,117— $012,794SEC↗
Wu Jinzi JasonDirector C Conversion2023-07-182023-07-201,654,701— $01,654,701SEC↗
SEIDENBERG BETH CDirector P Buy2023-07-182023-07-2046,875$16.00 $750.0K46,875SEC↗
SEIDENBERG BETH CDirector D To issuer2023-07-182023-07-2038,763— $00SEC↗
SEIDENBERG BETH CDirector A Award2023-07-182023-07-2038,763— $038,763SEC↗
SEIDENBERG BETH CDirector C Conversion2023-07-182023-07-201,860,712— $01,899,475SEC↗
SEIDENBERG BETH CDirector C Conversion2023-07-182023-07-2084,768— $084,768SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner J Other2023-07-182023-07-2038,763— $00SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner J Other2023-07-182023-07-2038,763— $038,763SEC↗
KPCB PANDEMIC & BIO DEFENSE FU10% Owner C Conversion2023-07-182023-07-201,860,712— $01,899,475SEC↗
KERINS PATRICK J10% Owner J Other2023-07-182023-07-2037,676— $00SEC↗
KERINS PATRICK J10% Owner J Other2023-07-182023-07-2037,676— $037,676SEC↗
KERINS PATRICK J10% Owner C Conversion2023-07-182023-07-203,769,857— $03,807,533SEC↗
KERINS PATRICK J10% Owner X Exercise2023-07-182023-07-2013,404$0.79 $10.6K3,820,937SEC↗
KERINS PATRICK J10% Owner S Sale2023-07-182023-07-20662$16.00 $10.6K3,820,275SEC↗
KERINS PATRICK J10% Owner P Buy2023-07-182023-07-2030,000$16.00 $480.0K3,850,275SEC↗